Orthofix Medical Inc. Debt Instrument, Fair Value Disclosure
Orthofix Medical Inc. (OFIX) had Debt Instrument, Fair Value Disclosure of $16.10 million as of 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentFairValue · last filed 2018-02-26
- 2017-12-31: Debt Instrument, Fair Value Disclosure $16.10M.
- 2017-03-31: Debt Instrument, Fair Value Disclosure $9.00M.
- 2016-12-31: Debt Instrument, Fair Value Disclosure $12.20M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2017-12-31 | $16.10M 10-K · filed 2018-02-26 |
| 2017-03-31 | $9.00M 10-K · filed 2018-02-26 |
| 2016-12-31 | $12.20M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |